169 related articles for article (PubMed ID: 1770532)
1. Substitution of cysteine for glycine at residue 415 of one allele of the alpha 1(I) chain of type I procollagen in type III/IV osteogenesis imperfecta.
Nicholls AC; Oliver J; Renouf DV; Keston M; Pope FM
J Med Genet; 1991 Nov; 28(11):757-64. PubMed ID: 1770532
[TBL] [Abstract][Full Text] [Related]
2. A de novo G to T transversion in a pro-alpha 1 (I) collagen gene for a moderate case of osteogenesis imperfecta. Substitution of cysteine for glycine 178 in the triple helical domain.
Valli M; Mottes M; Tenni R; Sangalli A; Gomez Lira M; Rossi A; Antoniazzi F; Cetta G; Pignatti PF
J Biol Chem; 1991 Jan; 266(3):1872-8. PubMed ID: 1988452
[TBL] [Abstract][Full Text] [Related]
3. Substitution of cysteine for glycine-alpha 1-691 in the pro alpha 1(I) chain of type I procollagen in a proband with lethal osteogenesis imperfecta destabilizes the triple helix at a site C-terminal to the substitution.
Steinmann B; Westerhausen A; Constantinou CD; Superti-Furga A; Prockop DJ
Biochem J; 1991 Nov; 279 ( Pt 3)(Pt 3):747-52. PubMed ID: 1953667
[TBL] [Abstract][Full Text] [Related]
4. Substitution of serine for glycine 883 in the triple helix of the pro alpha 1 (I) chain of type I procollagen produces osteogenesis imperfecta type IV and introduces a structural change in the triple helix that does not alter cleavage of the molecule by procollagen N-proteinase.
Lightfoot SJ; Atkinson MS; Murphy G; Byers PH; Kadler KE
J Biol Chem; 1994 Dec; 269(48):30352-7. PubMed ID: 7982948
[TBL] [Abstract][Full Text] [Related]
5. A cysteine for glycine substitution at position 175 in an alpha 1 (I) chain of type I collagen produces a clinically heterogeneous form of osteogenesis imperfecta.
Wirtz MK; Rao VH; Glanville RW; Labhard ME; Pretorius PJ; de Vries WN; de Wet WJ; Hollister DW
Connect Tissue Res; 1993; 29(1):1-11. PubMed ID: 8339541
[TBL] [Abstract][Full Text] [Related]
6. Two cysteine substitutions in procollagen I: a glycine replacement near the N-terminus of alpha 1(I) chain causes lethal osteogenesis imperfecta and a glycine replacement in the alpha 2(I) chain markedly destabilizes the triple helix.
Fertala A; Westerhausen A; Morris G; Rooney JE; Prockop DJ
Biochem J; 1993 Jan; 289 ( Pt 1)(Pt 1):195-9. PubMed ID: 8424758
[TBL] [Abstract][Full Text] [Related]
7. A point mutation in a type I procollagen gene converts glycine 748 of the alpha 1 chain to cysteine and destabilizes the triple helix in a lethal variant of osteogenesis imperfecta.
Vogel BE; Minor RR; Freund M; Prockop DJ
J Biol Chem; 1987 Oct; 262(30):14737-44. PubMed ID: 3667599
[TBL] [Abstract][Full Text] [Related]
8. Substitution of serine for alpha 1(I)-glycine 844 in a severe variant of osteogenesis imperfecta minimally destabilizes the triple helix of type I procollagen. The effects of glycine substitutions on thermal stability are either position of amino acid specific.
Pack M; Constantinou CD; Kalia K; Nielsen KB; Prockop DJ
J Biol Chem; 1989 Nov; 264(33):19694-9. PubMed ID: 2511192
[TBL] [Abstract][Full Text] [Related]
9. A lethal variant of osteogenesis imperfecta has a single base mutation that substitutes cysteine for glycine 904 of the alpha 1(I) chain of type I procollagen. The asymptomatic mother has an unidentified mutation producing an overmodified and unstable type I procollagen.
Constantinou CD; Nielsen KB; Prockop DJ
J Clin Invest; 1989 Feb; 83(2):574-84. PubMed ID: 2913053
[TBL] [Abstract][Full Text] [Related]
10. A single base mutation that converts glycine 907 of the alpha 2(I) chain of type I procollagen to aspartate in a lethal variant of osteogenesis imperfecta. The single amino acid substitution near the carboxyl terminus destabilizes the whole triple helix.
Baldwin CT; Constantinou CD; Dumars KW; Prockop DJ
J Biol Chem; 1989 Feb; 264(5):3002-6. PubMed ID: 2914942
[TBL] [Abstract][Full Text] [Related]
11. Substitution of cysteine for glycine-946 in the alpha 1(I) chain of type I procollagen causes lethal osteogenesis imperfecta.
Kurosaka D; Hattori S; Hori H; Yamaguchi N; Hasegawa T; Akimoto H; Nagai Y
J Biochem; 1994 May; 115(5):853-7. PubMed ID: 7961597
[TBL] [Abstract][Full Text] [Related]
12. Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a mutation in the COL1A2 gene of type I collagen. The mosaic parent exhibits phenotypic features of a mild form of the disease.
Edwards MJ; Wenstrup RJ; Byers PH; Cohn DH
Hum Mutat; 1992; 1(1):47-54. PubMed ID: 1301191
[TBL] [Abstract][Full Text] [Related]
13. Substitution of cysteine for glycine within the carboxyl-terminal telopeptide of the alpha 1 chain of type I collagen produces mild osteogenesis imperfecta.
Cohn DH; Apone S; Eyre DR; Starman BJ; Andreassen P; Charbonneau H; Nicholls AC; Pope FM; Byers PH
J Biol Chem; 1988 Oct; 263(29):14605-7. PubMed ID: 3170557
[TBL] [Abstract][Full Text] [Related]
14. Mutation in the carboxy-terminal propeptide of the Pro alpha 1(I) chain of type I collagen in a child with severe osteogenesis imperfecta (OI type III): possible implications for protein folding.
Oliver JE; Thompson EM; Pope FM; Nicholls AC
Hum Mutat; 1996; 7(4):318-26. PubMed ID: 8723681
[TBL] [Abstract][Full Text] [Related]
15. The molecular defect in an autosomal dominant form of osteogenesis imperfecta. Synthesis of type I procollagen containing cysteine in the triple-helical domain of pro-alpha 1(I) chains.
de Vries WN; de Wet WJ
J Biol Chem; 1986 Jul; 261(19):9056-64. PubMed ID: 3722186
[TBL] [Abstract][Full Text] [Related]
16. Osteogenesis imperfecta. The position of substitution for glycine by cysteine in the triple helical domain of the pro alpha 1(I) chains of type I collagen determines the clinical phenotype.
Starman BJ; Eyre D; Charbonneau H; Harrylock M; Weis MA; Weiss L; Graham JM; Byers PH
J Clin Invest; 1989 Oct; 84(4):1206-14. PubMed ID: 2794057
[TBL] [Abstract][Full Text] [Related]
17. Lethal osteogenesis imperfecta resulting from a single nucleotide change in one human pro alpha 1(I) collagen allele.
Cohn DH; Byers PH; Steinmann B; Gelinas RE
Proc Natl Acad Sci U S A; 1986 Aug; 83(16):6045-7. PubMed ID: 3016737
[TBL] [Abstract][Full Text] [Related]
18. Delayed triple helix formation of mutant collagen from patients with osteogenesis imperfecta.
Raghunath M; Bruckner P; Steinmann B
J Mol Biol; 1994 Feb; 236(3):940-9. PubMed ID: 8114103
[TBL] [Abstract][Full Text] [Related]
19. Osteogenesis imperfecta type IV: evidence of abnormal triple helical structure of type I collagen.
Wenstrup RJ; Hunter AG; Byers PH
Hum Genet; 1986 Sep; 74(1):47-53. PubMed ID: 3759085
[TBL] [Abstract][Full Text] [Related]
20. Substitutions for glycine alpha 1-637 and glycine alpha 2-694 of type I procollagen in lethal osteogenesis imperfecta. The conformational strain on the triple helix introduced by a glycine substitution can be transmitted along the helix.
Tsuneyoshi T; Westerhausen A; Constantinou CD; Prockop DJ
J Biol Chem; 1991 Aug; 266(24):15608-13. PubMed ID: 1874719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
